Acorah Software Products - Accounts Production 15.0.600 false true false true No description of principal activity 8 November 2022 30 November 2023 30 November 2023 14468809 Mr Shane Pakium iso4217:GBP iso4217:EUR iso4217:USD xbrli:shares xbrli:pure xbrli:pure 14468809 2022-11-07 14468809 2023-11-30 14468809 2022-11-08 2023-11-30 14468809 frs-core:CurrentFinancialInstruments 2023-11-30 14468809 frs-bus:PrivateLimitedCompanyLtd 2022-11-08 2023-11-30 14468809 frs-bus:FilletedAccounts 2022-11-08 2023-11-30 14468809 frs-bus:Micro-entities 2022-11-08 2023-11-30 14468809 frs-bus:AuditExempt-NoAccountantsReport 2022-11-08 2023-11-30 14468809 frs-bus:Director1 2022-11-08 2023-11-30
Registered number: 14468809
SMP Hypnotherapy Ltd
Unaudited Financial Statements
For the Period 8 November 2022 to 30 November 2023
TaxAssist Wolverhampton
Balance Sheet
Registered number: 14468809
30 November 2023
£
Fixed assets 3,038
Creditors: Amounts Falling Due Within One Year (1,601 )
NET CURRENT LIABILITIES (1,601 )
TOTAL ASSETS LESS CURRENT LIABILITIES 1,437
NET ASSETS 1,437
CAPITAL AND RESERVES 1,437

Notes

1. General Information
SMP Hypnotherapy Ltd is a private company, limited by shares, incorporated in England & Wales, registered number 14468809 . The registered office is 40 Rupert Street, Wolverhampton, WV3 9NS.
2. Average Number of Employees
Average number of employees, including directors, during the period was: NIL
-
For the period ending 30 November 2023 the company was entitled to exemption from audit under section 477 of the Companies Act 2006 relating to small companies.
The member has not required the company to obtain an audit in accordance with section 476 of the Companies Act 2006.
The director acknowledges his responsibilities for complying with the requirements of the Act with respect to accounting records and the preparation of accounts.
These accounts have been prepared in accordance with the micro-entity provisions and delivered in accordance with the provisions applicable to companies subject to the small companies' regime.
On behalf of the board
Mr Shane Pakium
Director
08/08/2024